BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 31395058)

  • 1. Is there a need for neoadjuvant short-course radiotherapy in T3 rectal cancer with positive lymph node involvement? A single-center retrospective cohort study.
    Räsänen M; Renkonen-Sinisalo L; Mustonen H; Lepistö A
    World J Surg Oncol; 2019 Aug; 17(1):139. PubMed ID: 31395058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rectal cancer: local recurrence after surgery without radiotherapy.
    Bonadeo FA; Vaccaro CA; Benati ML; Quintana GM; Garione XE; Telenta MT
    Dis Colon Rectum; 2001 Mar; 44(3):374-9. PubMed ID: 11289283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group trial 01.04.
    Ngan SY; Burmeister B; Fisher RJ; Solomon M; Goldstein D; Joseph D; Ackland SP; Schache D; McClure B; McLachlan SA; McKendrick J; Leong T; Hartopeanu C; Zalcberg J; Mackay J
    J Clin Oncol; 2012 Nov; 30(31):3827-33. PubMed ID: 23008301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic implications of MRI-detected lateral nodal disease and extramural vascular invasion in rectal cancer.
    Schaap DP; Ogura A; Nederend J; Maas M; Cnossen JS; Creemers GJ; van Lijnschoten I; Nieuwenhuijzen GAP; Rutten HJT; Kusters M
    Br J Surg; 2018 Dec; 105(13):1844-1852. PubMed ID: 30079958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can pathological complete response in the primary tumour following pre-operative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for sterilisation of pelvic lymph nodes, a low risk of local recurrence and the appropriateness of local excision?
    Hughes R; Glynne-Jones R; Grainger J; Richman P; Makris A; Harrison M; Ashford R; Harrison RA; Livingstone JI; McDonald PJ; Meyrick Thomas J; Mitchell IC; Northover JM; Phillips R; Wallace M; Windsor A; Novell JR
    Int J Colorectal Dis; 2006 Jan; 21(1):11-7. PubMed ID: 15864605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and Assessment of a Clinical Calculator for Estimating the Likelihood of Recurrence and Survival Among Patients With Locally Advanced Rectal Cancer Treated With Chemotherapy, Radiotherapy, and Surgery.
    Weiser MR; Chou JF; Keshinro A; Chapman WC; Bauer PS; Mutch MG; Parikh PJ; Cercek A; Saltz LB; Gollub MJ; Romesser PB; Crane CH; Shia J; Markowitz AJ; Garcia-Aguilar J; Gönen M;
    JAMA Netw Open; 2021 Nov; 4(11):e2133457. PubMed ID: 34748003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abdominoperineal resection for rectal cancer at a specialty center.
    Nissan A; Guillem JG; Paty PB; Douglas Wong W; Minsky B; Saltz L; Cohen AM
    Dis Colon Rectum; 2001 Jan; 44(1):27-35; discussion 35-6. PubMed ID: 11805560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant Radiotherapy Versus Surgery Alone for Stage II/III Mid-low Rectal Cancer With or Without High-risk Factors: A Prospective Multicenter Stratified Randomized Trial.
    Deng X; Liu P; Jiang D; Wei M; Wang X; Yang X; Zhang Y; Wu B; Liu Y; Qiu M; Zhuang H; Zhou Z; Li Y; Xu F; Wang Z
    Ann Surg; 2020 Dec; 272(6):1060-1069. PubMed ID: 31599809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of Local Recurrence and Oncologic Outcomes in T3 Low Rectal Cancer (≤5 cm from the Anal Verge) Treated With Short-Course Radiotherapy With Delayed Surgery : Outcomes in T3 Low Rectal Cancer Treated With Short-Course Radiotherapy With Delayed Surgery.
    Beppu N; Kimura F; Aihara T; Doi H; Tomita N; Yanagi H; Yamanaka N
    Ann Surg Oncol; 2017 Jan; 24(1):219-226. PubMed ID: 27699610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nomograms to predict survival and the risk for developing local or distant recurrence in patients with rectal cancer treated with optional short-term radiotherapy.
    van Gijn W; van Stiphout RGPM; van de Velde CJH; Valentini V; Lammering G; Gambacorta MA; Påhlman L; Bujko K; Lambin P
    Ann Oncol; 2015 May; 26(5):928-935. PubMed ID: 25609247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial.
    Erlandsson J; Holm T; Pettersson D; Berglund Å; Cedermark B; Radu C; Johansson H; Machado M; Hjern F; Hallböök O; Syk I; Glimelius B; Martling A
    Lancet Oncol; 2017 Mar; 18(3):336-346. PubMed ID: 28190762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is the Pathologic Response of T3 Rectal Cancer to High-Dose-Rate Endorectal Brachytherapy Comparable to External Beam Radiotherapy?
    Garfinkle R; Lachance S; Vuong T; Mikhail A; Pelsser V; Gologan A; Morin NA; Vasilevsky CA; Boutros M
    Dis Colon Rectum; 2019 Mar; 62(3):294-301. PubMed ID: 30741768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of lymphadenectomy in patients receiving neoadjuvant radiotherapy for rectal adenocarcinoma.
    Le M; Nelson R; Lee W; Mailey B; Duldulao M; Chen YJ; Garcia-Aguilar J; Kim J
    Ann Surg Oncol; 2012 Nov; 19(12):3713-8. PubMed ID: 22688661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of patients with clinical stage II or III rectal cancer treated without adjuvant radiotherapy.
    Fujita S; Yamamoto S; Akasu T; Moriya Y
    Int J Colorectal Dis; 2008 Nov; 23(11):1073-9. PubMed ID: 18594841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of adjuvant radiotherapy on local recurrence in stage II rectal cancer.
    Park IJ; Kim HC; Yu CS; Kim TW; Jang SJ; Kim JC
    Ann Surg Oncol; 2008 Feb; 15(2):519-25. PubMed ID: 17960464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymph node yield in rectal cancer surgery: effect of preoperative chemoradiotherapy.
    Morcos B; Baker B; Al Masri M; Haddad H; Hashem S
    Eur J Surg Oncol; 2010 Apr; 36(4):345-9. PubMed ID: 20071133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiotherapy does not compensate for positive resection margins in rectal cancer patients: report of a multicenter randomized trial.
    Marijnen CA; Nagtegaal ID; Kapiteijn E; Kranenbarg EK; Noordijk EM; van Krieken JH; van de Velde CJ; Leer JW;
    Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1311-20. PubMed ID: 12654443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative radiotherapy improves survival for patients undergoing total mesorectal excision for stage T3 low rectal cancers.
    Delaney CP; Lavery IC; Brenner A; Hammel J; Senagore AJ; Noone RB; Fazio VW
    Ann Surg; 2002 Aug; 236(2):203-7. PubMed ID: 12170025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lateral Nodal Features on Restaging Magnetic Resonance Imaging Associated With Lateral Local Recurrence in Low Rectal Cancer After Neoadjuvant Chemoradiotherapy or Radiotherapy.
    Ogura A; Konishi T; Beets GL; Cunningham C; Garcia-Aguilar J; Iversen H; Toda S; Lee IK; Lee HX; Uehara K; Lee P; Putter H; van de Velde CJH; Rutten HJT; Tuynman JB; Kusters M;
    JAMA Surg; 2019 Sep; 154(9):e192172. PubMed ID: 31268504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients.
    Bonnen M; Crane C; Vauthey JN; Skibber J; Delclos ME; Rodriguez-Bigas M; Hoff PM; Lin E; Eng C; Wong A; Janjan NA; Feig BW
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1098-105. PubMed ID: 15519780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.